About HUMCO
HUMCO is a Healthcare company based in Austin (United States) founded in 1872, and was acquired by Fagron in April 2018. Topical creams, syrups, suspensions, and APIs are manufactured. Its chief executive, as recorded, is Andrew Pulido. HUMCO offers products and services including OTC Medicines and Private Label Products. Its focus areas include Biopharma Outsourcing, CDMO and Small Molecules & Peptides. Its competitors include Asymchem and Continuus Pharma; 1 of its 2 listed competitors has raised funding.
Company details
HUMCO was founded in 1872 in Austin, United States, and operates in the pharmaceutical sector. APIs and over-the-counter formulations are produced, including topical and transdermal creams, syrups, and suspensions across categories such as analgesics, anti-infectives, wound care, and dermatology. Drug delivery vehicles for gels, creams, and oral liquids are also manufactured.
Products & Services of HUMCO
HUMCO offers a comprehensive portfolio of products and services, including OTC Medicines and Private Label Products.
High-quality over-the-counter medicines for consumer health needs
Premium branded items supplied to retailers and wholesalers
Investors in HUMCO
HUMCO has secured backing from 1 investor. Prominent investors backing the company include Fagron.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
Drug compounding services are provided by Fagron. | 1990 | fagron.com | Saint Paul, United States |
Investor details for HUMCO
The complete investor list, round-by-round participation and investor portfolios require an active premium plan.
- Complete investor list
- Round participation
- Investor portfolios
- Co-investor network
Verified entity values are shown only after access is granted.
People of HUMCO
1 people are tracked at HUMCO (1 in leadership).
| Name | Role | Group |
|---|---|---|
Andrew Pulido | CEO | Leadership |
Complete people profiles for HUMCO
Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.
- Full employee list
- Team structure
- Board tenure
- Professional contacts
Verified entity values are shown only after access is granted.
Timeline of HUMCO
2 dated milestones of HUMCO across 146 years, from founding to its latest funding, stage changes and deals.
- Founded HUMCO is founded.
- Exit Acquired by Fagron.
Competitors of HUMCO
HUMCO has 2 listed competitors in our database, 1 of them funded. They include Asymchem and Continuus Pharma.
| Company Name | Domain | Founded | HQ Location | Total funding | Employees | Description |
|---|---|---|---|---|---|---|
| asymchem.com | 1995 | Morrisville, United States | 48 | APIs and peptides are developed and manufactured by Asymchem. | ||
| continuuspharma.com | 2012 | Woburn, United States | $7.73M | 47 | MIT-Novartis spinoff offering continuous manufacturing solutions to remove the proverbial wall between API and FDF manufacturing in small molecule development |
Detailed competitors of HUMCO
The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.
- Full competitor set
- Operating metrics
- Benchmarks
- Competitive positioning
Verified entity values are shown only after access is granted.
Web traffic of HUMCO
Websites that share an audience with HUMCO (humco.com).
Websites whose visitors overlap most with HUMCO. Affinity shows how closely the audiences match.
| Website | Domain | Audience affinity | Monthly visits | Global rank | Profile |
|---|---|---|---|---|---|
naturalcompounder.com | naturalcompounder.com | 100% | #3,632,970 | β | |
| healthunit.com | 100% | #931,998 | View details | ||
sombrausa.com | sombrausa.com | 99% | #3,944,298 | β | |
bbpharmacy.com | bbpharmacy.com | 71% | #6,844,607 | β |
Top companies in Biopharma Outsourcing & Drug Delivery
3 companies that operate in the same segment as HUMCO (Biopharma Outsourcing & Drug Delivery) in United States, ranked by their profile score on The Company Check.
| Company | Description | Founded | Location | Total funding | Revenue | Employees |
|---|---|---|---|---|---|---|
Suite solutions are provided for payers and healthcare providers. | 1998 | Princeton, New Jersey, United States | USD 220 M | USD 374.1 M | 5,666 | |
Wearable insulin infusion systems are developed for diabetes patients. | 2000 | Boston, Massachusetts, United States | USD 120.4 M | USD 2.71 B | 3,900 | |
Developer of small-molecule drugs | 1991 | Los Angeles, California, United States | USD 50 M | USD 348.97 M | 407 |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track β from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Related news about Humco
Complete news archive for HUMCO
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about HUMCO
HUMCO was founded in 1872.
HUMCO is headquartered in Austin, United States. It is registered at Austin, Texas, United States.
Andrew Pulido is the CEO of HUMCO, as recorded in our data.
HUMCO was founded in 1872 in Austin, United States, and operates in the pharmaceutical sector. APIs and over-the-counter formulations are produced, including topical and transdermal creams, syrups, and suspensions across categories such as analgesics, anti-infectives, wound care, and dermatology. Drug delivery vehicles for gels, creams, and oral liquids are also manufactured.
HUMCO's top competitors include Asymchem and Continuus Pharma.
HUMCO offers OTC Medicines and Private Label Products.
HUMCO has 1 investor. Key investors include Fagron.
Yes. HUMCO was acquired by Fagron in April 2018.

